annual CFI:
-$508.19M-$345.13M(-211.66%)Summary
- As of today (May 21, 2025), JAZZ annual cash flow from investing activities is -$508.19 million, with the most recent change of -$345.13 million (-211.66%) on December 31, 2024.
- During the last 3 years, JAZZ annual CFI has risen by +$4.70 billion (+90.25%).
- JAZZ annual CFI is now -9622.11% below its all-time high of $5.34 million, reached on December 31, 2007.
Performance
JAZZ Cash from investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFI:
-$168.93M+$24.36M(+12.60%)Summary
- As of today (May 21, 2025), JAZZ quarterly cash flow from investing activities is -$168.93 million, with the most recent change of +$24.36 million (+12.60%) on March 1, 2025.
- Over the past year, JAZZ quarterly CFI has increased by +$102.97 million (+37.87%).
- JAZZ quarterly CFI is now -122.92% below its all-time high of $737.13 million, reached on March 31, 2021.
Performance
JAZZ quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFI:
-$405.22M+$102.97M(+20.26%)Summary
- As of today (May 21, 2025), JAZZ TTM cash flow from investing activities is -$405.22 million, with the most recent change of +$102.97 million (+20.26%) on March 1, 2025.
- Over the past year, JAZZ TTM CFI has increased by +$24.92 million (+5.79%).
- JAZZ TTM CFI is now -647.40% below its all-time high of $74.03 million, reached on September 30, 2013.
Performance
JAZZ TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
JAZZ Cash from investing Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -211.7% | +37.9% | +5.8% |
3 y3 years | +90.3% | -353.0% | +93.2% |
5 y5 years | -227.2% | -181.2% | -6.2% |
JAZZ Cash from investing Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -211.7% | +90.3% | -178.9% | +47.9% | -207.1% | +93.2% |
5 y | 5-year | -227.2% | +90.3% | -122.9% | +97.1% | -207.1% | +93.2% |
alltime | all time | -9622.1% | +90.3% | -122.9% | +97.1% | -647.4% | +93.2% |
JAZZ Cash from investing History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2025 | - | -$168.93M(-12.6%) | -$405.22M(-20.3%) |
Dec 2024 | -$508.19M(+211.7%) | -$193.29M(-190.3%) | -$508.19M(+138.5%) |
Sep 2024 | - | $214.09M(-183.3%) | -$213.11M(-64.6%) |
Jun 2024 | - | -$257.09M(-5.4%) | -$601.50M(+39.8%) |
Mar 2024 | - | -$271.90M(-367.1%) | -$430.14M(+163.8%) |
Dec 2023 | -$163.06M(-63.5%) | $101.80M(-158.4%) | -$163.06M(-72.3%) |
Sep 2023 | - | -$174.30M(+103.3%) | -$589.24M(+43.6%) |
Jun 2023 | - | -$85.74M(+1678.1%) | -$410.34M(-0.8%) |
Mar 2023 | - | -$4.82M(-98.5%) | -$413.76M(-7.3%) |
Dec 2022 | -$446.23M(-91.4%) | -$324.38M(-7148.6%) | -$446.23M(+238.2%) |
Sep 2022 | - | $4.60M(-105.2%) | -$131.94M(-19.2%) |
Jun 2022 | - | -$89.16M(+139.1%) | -$163.36M(-97.3%) |
Mar 2022 | - | -$37.29M(+269.5%) | -$5.99B(+14.9%) |
Dec 2021 | -$5.21B(+417.2%) | -$10.09M(-62.4%) | -$5.21B(+1.6%) |
Sep 2021 | - | -$26.81M(-99.5%) | -$5.13B(-4.7%) |
Jun 2021 | - | -$5.91B(-902.1%) | -$5.38B(+2457.1%) |
Mar 2021 | - | $737.13M(+906.7%) | -$210.46M(-79.1%) |
Dec 2020 | -$1.01B(+548.9%) | $73.22M(-126.2%) | -$1.01B(-18.7%) |
Sep 2020 | - | -$279.64M(-62.3%) | -$1.24B(+10.7%) |
Jun 2020 | - | -$741.16M(+1133.6%) | -$1.12B(+193.6%) |
Mar 2020 | - | -$60.08M(-62.2%) | -$381.43M(+145.6%) |
Dec 2019 | -$155.30M(-60.6%) | -$159.05M(-0.4%) | -$155.30M(-455.0%) |
Sep 2019 | - | -$159.66M(+5952.4%) | $43.74M(+275.2%) |
Jun 2019 | - | -$2.64M(-101.6%) | $11.66M(-106.6%) |
Mar 2019 | - | $166.05M(+315.2%) | -$176.29M(-55.3%) |
Dec 2018 | -$394.49M(+46.7%) | $39.99M(-120.9%) | -$394.49M(-15.4%) |
Sep 2018 | - | -$191.75M(+0.6%) | -$466.36M(-2.4%) |
Jun 2018 | - | -$190.58M(+265.5%) | -$477.96M(+50.5%) |
Mar 2018 | - | -$52.15M(+63.6%) | -$317.52M(+18.1%) |
Dec 2017 | -$268.95M(-84.6%) | -$31.88M(-84.3%) | -$268.95M(+12.6%) |
Sep 2017 | - | -$203.35M(+574.4%) | -$238.93M(-84.7%) |
Jun 2017 | - | -$30.15M(+743.6%) | -$1.57B(-10.1%) |
Mar 2017 | - | -$3.57M(+92.3%) | -$1.74B(-0.5%) |
Dec 2016 | -$1.75B(>+9900.0%) | -$1.86M(-99.9%) | -$1.75B(-0.1%) |
Sep 2016 | - | -$1.53B(+642.3%) | -$1.75B(+672.8%) |
Jun 2016 | - | -$206.27M(+1619.6%) | -$226.79M(+596.9%) |
Mar 2016 | - | -$11.99M(+256.3%) | -$32.54M(+1343.1%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2015 | -$2.25M(-99.8%) | -$3.37M(-34.7%) | -$2.25M(-82.7%) |
Sep 2015 | - | -$5.16M(-57.1%) | -$13.06M(-85.7%) |
Jun 2015 | - | -$12.02M(-165.7%) | -$91.04M(-1.2%) |
Mar 2015 | - | $18.29M(-229.1%) | -$92.15M(-91.4%) |
Dec 2014 | -$1.07B(+6464.5%) | -$14.17M(-83.0%) | -$1.07B(+1.0%) |
Sep 2014 | - | -$83.14M(+533.1%) | -$1.06B(+8.2%) |
Jun 2014 | - | -$13.13M(-98.6%) | -$976.59M(+1.0%) |
Mar 2014 | - | -$957.20M(>+9900.0%) | -$967.02M(+5845.8%) |
Dec 2013 | -$16.26M(-95.9%) | -$3.10M(-1.6%) | -$16.26M(-122.0%) |
Sep 2013 | - | -$3.15M(-11.6%) | $74.03M(+0.8%) |
Jun 2013 | - | -$3.57M(-44.6%) | $73.43M(-115.2%) |
Mar 2013 | - | -$6.44M(-107.4%) | -$484.25M(+22.5%) |
Dec 2012 | -$395.29M(+386.6%) | $87.19M(-2425.7%) | -$395.29M(-27.9%) |
Sep 2012 | - | -$3.75M(-99.3%) | -$548.08M(-1.8%) |
Jun 2012 | - | -$561.24M(-780.2%) | -$557.96M(<-9900.0%) |
Mar 2012 | - | $82.51M(-225.8%) | $2.47M(-103.0%) |
Dec 2011 | -$81.23M(+3690.6%) | -$65.60M(+381.6%) | -$81.23M(+385.1%) |
Sep 2011 | - | -$13.62M(+1561.2%) | -$16.75M(+326.1%) |
Jun 2011 | - | -$820.00K(-31.2%) | -$3.93M(-8.3%) |
Mar 2011 | - | -$1.19M(+7.0%) | -$4.29M(+100.0%) |
Dec 2010 | -$2.14M(-65.0%) | -$1.11M(+38.1%) | -$2.14M(-64.7%) |
Sep 2010 | - | -$806.00K(-31.4%) | -$6.07M(-15.3%) |
Jun 2010 | - | -$1.18M(-223.6%) | -$7.17M(+13.7%) |
Mar 2010 | - | $951.00K(-118.9%) | -$6.31M(+3.0%) |
Dec 2009 | -$6.12M(-48.7%) | -$5.04M(+164.8%) | -$6.12M(-24.2%) |
Sep 2009 | - | -$1.91M(+510.6%) | -$8.07M(<-9900.0%) |
Jun 2009 | - | -$312.00K(-127.4%) | $51.00K(-100.6%) |
Mar 2009 | - | $1.14M(-116.3%) | -$7.88M(-34.0%) |
Dec 2008 | -$11.94M(-323.8%) | -$6.99M(-212.4%) | -$11.94M(-367.9%) |
Sep 2008 | - | $6.22M(-175.5%) | $4.46M(-133.7%) |
Jun 2008 | - | -$8.24M(+181.6%) | -$13.23M(+112.3%) |
Mar 2008 | - | -$2.93M(-131.1%) | -$6.23M(-216.8%) |
Dec 2007 | $5.34M(-454.1%) | $9.40M(-182.0%) | $5.34M(-231.2%) |
Sep 2007 | - | -$11.47M(+823.5%) | -$4.07M(-155.0%) |
Jun 2007 | - | -$1.24M(-114.4%) | $7.40M(-14.4%) |
Mar 2007 | - | $8.64M | $8.64M |
Dec 2006 | -$1.51M(-99.0%) | - | - |
Dec 2005 | -$153.75M | - | - |
FAQ
- What is Jazz Pharmaceuticals annual cash flow from investing activities?
- What is the all time high annual CFI for Jazz Pharmaceuticals?
- What is Jazz Pharmaceuticals annual CFI year-on-year change?
- What is Jazz Pharmaceuticals quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Jazz Pharmaceuticals?
- What is Jazz Pharmaceuticals quarterly CFI year-on-year change?
- What is Jazz Pharmaceuticals TTM cash flow from investing activities?
- What is the all time high TTM CFI for Jazz Pharmaceuticals?
- What is Jazz Pharmaceuticals TTM CFI year-on-year change?
What is Jazz Pharmaceuticals annual cash flow from investing activities?
The current annual CFI of JAZZ is -$508.19M
What is the all time high annual CFI for Jazz Pharmaceuticals?
Jazz Pharmaceuticals all-time high annual cash flow from investing activities is $5.34M
What is Jazz Pharmaceuticals annual CFI year-on-year change?
Over the past year, JAZZ annual cash flow from investing activities has changed by -$345.13M (-211.66%)
What is Jazz Pharmaceuticals quarterly cash flow from investing activities?
The current quarterly CFI of JAZZ is -$168.93M
What is the all time high quarterly CFI for Jazz Pharmaceuticals?
Jazz Pharmaceuticals all-time high quarterly cash flow from investing activities is $737.13M
What is Jazz Pharmaceuticals quarterly CFI year-on-year change?
Over the past year, JAZZ quarterly cash flow from investing activities has changed by +$102.97M (+37.87%)
What is Jazz Pharmaceuticals TTM cash flow from investing activities?
The current TTM CFI of JAZZ is -$405.22M
What is the all time high TTM CFI for Jazz Pharmaceuticals?
Jazz Pharmaceuticals all-time high TTM cash flow from investing activities is $74.03M
What is Jazz Pharmaceuticals TTM CFI year-on-year change?
Over the past year, JAZZ TTM cash flow from investing activities has changed by +$24.92M (+5.79%)